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Background: Abnormalities in reinforcement learning and
reversal learning have been reported in psychosis, possibly
secondary to subcortical dopamine abnormalities. Meth-
ods: We studied simple discrimination (SD) learning and
reversal learning in a sample of 119 first-episode psychosis
patients from the Cambridge early psychosis service
(CAMEO) and 107 control participants. We used data
on reinforcement learning and reversal learning extracted
from the Cambridge Neuropsychological Test Automated
Battery Intradimensional-Extradimensional shift task,
whichmeasurescognitiveflexibilitybutalsoinvolvessimple
reinforcement learning (SD learning) and reversal learning
stages. We also gathered diagnostic information to exam-
ine whether there were any differences between patients ul-
timately diagnosed with schizophrenia-spectrum disorders
and those diagnosed with affective psychosis. Results: Psy-
chosis patients demonstrated deficits in simple reinforce-
ment learning (SD learning) and in reversal learning,
with no differences between affective psychosis and schizo-
phrenia-spectrum psychosis. There was a significant mod-
est correlation between reversal errors and negative
symptoms (Spearman r = 0.3, P = .02). Conclusions:
There are reinforcement learning abnormalities in first-
episodepsychosis,which correlatewithnegativesymptoms,
suggesting a possible role for orbitofrontal cortex and ven-
tral striatal pathology in the pathogenesis of motivational
deficits in psychosis.
Key words: neuropsychology/cognitive function/
schizophrenia/orbitofrontal cortex/ventral striatum/set
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Introduction
It has long been proposed that there are associative and
reinforcement learning deficits in schizophrenia and
other psychoses.
1–7 Such theories have been strengthened
bydocumentation of dopamine deficits in the pathophys-
iology and treatment of schizophrenia,
8,9 given evidence
from animal
10,11 and human
12 studies implicating a criti-
cal role for dopamine transmission in reinforcement
learning. Until recently, reinforcement learning in psy-
chosis has received little laboratory study. However, ini-
tial evidence has recently emerged demonstrating
abnormalreinforcementlearning,coupledwithdisrupted
activity of dopamine innervated brain regions in schizo-
phrenia and other psychoses.
13–15
Reinforcement learning, in its general sense, involves
a subject learning by trial-and-error feedback to select
actions that maximize reward over time. One variant
of reinforcement learning, termed reversal learning,
examines the ability to flexibly adapt the response to
a change in learning contingencies. Reversal learning is
of particular interest in psychotic illness as a marker of
functioning in orbitofrontal cortex–ventral striatal cir-
cuitry. Other orbitofrontal cortex–related paradigms,
such as the Iowa Gambling Test, have yielded equivocal
results in schizophrenia.
16,17 Three previous studies have
specifically examined reversal learning in psychosis, each
finding deficits, but these few existing studies have sam-
pled only patients with chronic schizophrenia.
18–20 It
remains unclear whether reinforcement and reversal
learning are dysfunctional in the early phase of schizo-
phrenia and whether these processes are differentially im-
paired in schizophreniform psychoses and affective
psychoses. We therefore examined simple reinforcement
and reversal learning in a large sample of first-episode
psychosis patients who undertook the Intra-Extra Di-
mensional (ID/ED) Set Shift task from the Cambridge
Neuropsychological Test Automated Battery (CANTAB)
cognitive test battery.
21 The ID/ED test involves various
stages of rule learning and rule reversal, as well as the
formation of attentional set. Because of the highly
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848structured progression of the task, it is possible to exam-
ine specific cognitive-behavioral components involved at
differentstagesoftheexperiment.Wespecificallyfocused
on performance of those parts of the test involving rever-
sal learning and compared performance in psychosis
patients with matched controls. Furthermore, we fol-
lowed up patients presenting with first-episode psychosis,
and stratified their performance according to formal diag-
nosticstatusafter12months.Inthisreport,wedonotfocus
on ED set shifting performance, as performance there has
previouslybeenwellstudiedinearlypsychosis,
22including
in a partially overlapping sample.
23
Methods
Participants
One hundred nineteen individuals (mean age 23.4 years;
88 men) with first-episode psychosis were recruited from
the Cambridge first-episode psychosis service, Cambridge
early psychosis service (CAMEO; www.cameo.nhs.uk),
for the study. Inclusion criteria for CAMEO is age be-
tween 17 and 35 years, suffering from a first episode of
psychosis as defined by the Melbourne criteria of the
presence of psychotic symptoms for at least a week,
24
and duration of antipsychotic treatment of under 6
months at time of initial assessment. One hundred seven
healthy volunteers (mean age 24.5 years, 72 men) were
recruited from the general population by advertisement
to act as a control group. The majority of the patients
were taking second-generation antipsychotic medication.
Most patients in this study were assessed within 6 weeks
of their referral to CAMEO and had mild symptoms at
the time of the experiment. Twelve months after the ex-
periment, a psychiatrist (G.K.M.) utilized all available
clinical information including case history, ongoing clin-
ical assessments, structured clinical interview for Diag-
nostic and Statistical Manual of Mental Disorders,
Fourth Edition,
25 and operational criteria diagnostic sys-
tem
26toclassifythe casesasaffective psychosisor nonaf-
fectivepsychosis.TheresearchwasapprovedbytheLocal
Research Ethics Committee; all participants provided
written informed consent. The National Adult Reading
Test was used to estimate IQ of patients and controls.
ID/ED Shift Test
The ID/ED Shift test was derived from the Wisconsin
Card Sort Test.
27 It involves visual discrimination and
attentional set formation and tests the maintenance,
shifting, and flexibility of attention (see figure 1). Two
dimensions are used in the test: color-filled shapes and
white lines. Simple stimuli are made up of just one of
these dimensions, whereas compound stimuli are made
up of both, namely white lines overlying color-filled
shapes. At the first stage, simple discrimination (SD),
the subject starts by seeing 2 simple color-filled shapes,
and must learn which one is correct by touching it. Feed-
back teaches the subject which stimulus is correct, and
after 6 correct responses, the contingencies change and
the previously correct element becomes incorrect (simple
reversal stage). At this point distracting stimuli (lines) are
added in order to provide compound discrimination
stages (CD1 and CD2), followed by compound discrim-
ination reversal. After this stage has been learnt, there is
an intradimensional shift (IDS), where new exemplars of
the 2 dimensions ‘‘line’’ and ‘‘shape’’ are introduced, but
the relevant dimension is unchanged, eg, color-filled
shapes remain the only relevant dimension. After an
intradimensional reversal (IDR), there follows an extra-
dimensional shift (EDS, eg, white lines become the rele-
vant dimension) and a final reversal stage (EDR).
Subjects progress through the test by satisfying a set cri-
terion of learning at each stage (6 consecutive correct
responses). We extracted information on all stages but
focus our analysis on the basic acquisition and reversal
trials. In cognitive assessments, the ID/ED test is some-
times preceded by a preliminary test called Big/Little Cir-
cle, which is a screening test in the CANTAB test battery;
we did not use the Big/Little Circle test in our study.
Data Analysis
Demographiccharacteristicsofthe2groups,andnumber
of subjects failing test stages, were compared using inde-
pendent samples t tests and chi-squared tests. Error
scores were skewed and could not be normalized by
mathematical transformation, and were therefore ana-
lysed with Mann-Whitney U Tests. Because error scores
are count data, the relationship between error scores and
symptomsscoreswereimplementedusing Poissonregres-
sion in intercooled Stata 8.2. Separate analyses with error
score as the dependent variable were employed for each
predictor variable, and the results confirmed with corre-
lational analyses using Spearman q.
Results
Group demographics and diagnostic information:
The psychosis group and the control group were matched
onage,gender,andNARTestimatedverbalIQ(Table1).
When all available information was utilized to apply di-
agnosticcategoriesafter12months,81patientswereclas-
sified as schizophrenia-spectrum psychosis and 31 as
affective psychosis, with missing information on 6 cases.
PANSS scores from initial assessment were available on
78 patients.
Learning analysis: stages passed and failed
Inthecontrolgroup,1participantfailed attheIDSstage,
2 failed at the IDR stage, 5 failed at the EDS stage, and 1
failed at the final reversal stage (see figure 2). In patients,
2 failed at the compound discrimination stage, 1 at the
compound reversal stage, 27 failed at the EDS stage,
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849and 11 failed at the final reversal stage. Thus, in terms of
stage failures, significantly more patients failed the EDS
stage (v = 16.5, P < .001), and the final reversal stage (v =
9.6, P < .01), than controls.
Learning analysis: error analysis
Foramoresensitiveanalysis,weexaminederrorscoresat
each stage. We compared all patients (n = 119) vs all con-
trols(n=107)oninitialdiscriminationlearning(figure3).
By examining the number of errors using the Mann-
Whitney U test, we confirmed that psychosis patients
made more errors than controls during initial discrimina-
tion learning (z = 2.5, P = .01); in contrast, there were no
differences between patients and controls on initial rever-
sal learning, compound discrimination learning, ID set
shifting, compound reversal, or IDR. However, there
were deficits in ED set shifting (z =  5.1, P < .001)
and final reversal stages (z =  3.7, P < .001). Next, we
examined the total number of reversal errors over the
course of the experiment in participants who attempted
all stages of the IDED test: ie, those who completed
at least the EDS stage and so could attempt the final re-
versal stage (99 controls and 89 patients, see table 2 and
figure 4). Although some psychosispatients showed good
performance, as a group patients made more total rever-
sal errors than controls (z =  2.4, P = .02).
We next examined whether, within the patient group,
total reversal errors could be explained, at least in part,
by SD errors. Utilizing Poisson regression, we found that
SDerrorsdidnotpredicttotalreversalerrors(z=0.7,P=.5).
In contrast, SD errors were a significant predictor of
EDS errors (z = 5.4, P < .001).
Having established the differences between first-
episode psychosis patients and controls, we proceeded
to examine whether patients with schizophrenia-spectrum
psychoses differed from patients with affective psychosis.
Patients with affective psychosis made fewer ID shifting
Fig. 1. Schematic of the Intradimensional-Extradimensional Shift Task From the Cambridge Neuropsychological Test Automated Battery
(CANTAB). The correct choice for each stage is marked with a green box. Copyright 2008 Cambridge Cognition, Ltd. All rights reserved.
Table1. DemographicInformationonPsychosisCasesandControlsandonPsychosisPatientsStratifiedbyDiagnosisofNonaffectiveor
Affective Psychosis (Diagnostic Information Was Missing on 6 Patients)
Control,
Mean
(SD)
All Psychosis,
Mean
(SD)
Nonaffective
Psychosis,
Mean (SD)
Affective
Psychosis,
Mean (SD)
T
or v
2 df P
Age (y) 24.5 (4.7) 23.3 (5.4) 23.6 (5.6) 24.2 (1.1) 1.6 224 .1
NART 112 (13) 109 (8) 108 (8.2) 111 (7.8) 1.9 175 .1
Gender 72 Men, 35 women 88 Men, 31 women 63 Men, 19 women 20 Men, 11 women 1.2 1 .3
PANSS positive N/A 16.9 (6.2) 18.4 (6.2) 13.6 (5.2)
PANSS negative N/A 14.5 (6.6) 15.4 (6.7) 12.2 (6.0)
Note: Also shown are statistical comparisons of psychosis patients vs controls in age, National Adult Reading Test Score, and gender.
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(z =  2.3, P = .026), but there were no differences in
any other stages of the ID/ED or in total reversal errors
(z =  0.539, P = .6; table 3).
Finally, we examined whether symptom scores corre-
lated with performance on simple and reversal trials in
the 56 first-episode psychosis patients who completed
at least the ED stage of the ID/ED test and for whom
PANSS scores were available. Poisson regression
revealed that total reversal errors were predicted by neg-
ative symptoms (z = 3.72, P < .001), but not positive
symptoms (z =  0.6, P = .6), which is consistent with
results from a correlational analysis: total reversal errors
correlatedsignificantlywithnegativesymptoms(Spearman
q = 0.3, P = .02) but not with positive symptoms
(Spearman q = 0.2, P = .20). There was no association
between SD errors and psychopathology either on cor-
relational analysis (positive symptoms Spearman q =
0.06, P = .6; negative symptoms Spearman q = 0.02,
P = .98) or on Poisson regression (positive symptoms
z = 0.52, P = .6, negative symptoms z = 0.35, P = .7).
Fig. 4. Total Reversal Learning Errors in Psychosis Cases and
Controls.
Fig. 3. Simple Discrimination Errors in Psychosis Cases and
Controls.
Fig. 2. Attrition at Each Stage of the Intradimensional-
Extradimensional Test. SD, simple discrimination; SR, simple
reversal; CD1, compound discrimination 1; CD2, compound
discrimination 2; CDR, compound discrimination reversal; IDS,
intradimensional shift; IDR, intradimensional reversal; EDS,
extradimensional shift; EDR, extradimensional reversal. Asterisk
indicates group difference P< .01.
Table2. ComparisonofPsychosisCasesandControlErrorScores
(Mann-WhitneyUTest)inThoseParticipantsWhoAttemptedAll
Stages of the IDED Test: ie, Those Who Completed At Least the
ExtradimensionalShiftStageandWhoThereforeWereAbletoAt
Least Attempt the Final Reversal Stage
Psychosis
N = 89
Mean (SD)
Control
N = 98
Mean (SD) zP
Simple
discrimination
0.84 (0.62) 0.68 (0.75)  2.33 0.02
Simple reversal 1.27 (0.72) 1.27 (0.75)  0.04 1
Compound
discrimination 1
1.06 (1.41) 1.04 (1.61)  0.03 1
Compound
discrimination 2
0.22 (0.56) 0.15 (0.48)  0.92 0.4
Compound
reversal
1.64 (1.71) 1.48 (1.51)  0.62 0.5
Intradimensional
shift
0.67 (1.19) 0.67 (1.37)  0.22 0.8
Intradimensional
reversal
1.30 (0.86) 1.32 (0.97)  0.14 0.9
Extradimensional
shift
6.55 (5.66) 4.36 (4.45)  3.44 <0.001
Extradimensional
reversal
5.31 (8.39) 1.40 (1.20)  3.71 <0.001
Total reversal
errors
9.60 (9.11) 5.72 (3.62)  2.41 0.02
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Asexpected,wefoundthatpsychosispatientshaddeficits
in ED set shifting. This deficit has been previously docu-
mentedinchronicschizophrenia
19,28–30andinfirst-episode
psychosis,
23 although some studies in first-episode psy-
chosis suggest that there may either be no deficit in
this domain
31 or that the deficit may be slight.
22,32
Given that a number of previous studies have investi-
gated ED set shifting in schizophrenia and early psycho-
sis, here we focus our interpretation on the results
concerning simple reinforcement learning and reversal
learning.
Elliott et al
18 and Pantelis et al
28 previously demon-
stratedreversallearningdeficitsinchronicschizophrenia.
Both these groups extracted reversal learning perfor-
mance from a version of the ID/ED test: the same ap-
proach that we employ in this study. Waltz and
Gold
20 showed profound reversal deficits in 34 patients
with chronic schizophrenia using a different method;
they employed a probabilistic reversal task adapted
from Robbins and colleagues.
33,34 Our results demon-
strate that reversal learning deficits are also present in
many patients near the time of initial presentation to psy-
chiatric services. We note that these deficits were not uni-
versal however, and many patients performed at
comparable levels to controls (see figure 4).
In contrast to Waltz and Gold,
20 who argued that
patients performed adequately on rule acquisition, we
were able to detect subtle abnormalities in simple rein-
forcement learning (SD learning), possibly because of
our large sample size. Our study thus provides further
support to long-held contentions that there are reinforce-
ment learning abnormalities in psychosis. Discrimination
learning has been shown to be impaired by caudate tail
lesions
35; previous data supports caudate dysfunction in
psychosis.
13,36,37 Specifically, the tail of the caudate is
itself connected to the medial temporal lobe, an area
that is strongly implicated in the pathogenesis of psy-
chotic illness
38 as well as playing a role in discrimination
learning. Research in rhesus monkeys has shown that
lesions to the medial temporal lobe rhinal cortex, and
to the inferior temporal cortex, result in mild and severe
deficits, respectively, in discrimination learning, possibly
through an inferior temporal-frontal-thalamic net-
work.
39–43 Thus, the SD deficit we note is also consistent
withpreviousevidencefordisruptedfrontotemporalcon-
nectivity in psychosis.
44,45
Patients with affective and nonaffective psychosis did
not differ significantly in reversal learning errors (or in-
deed in EDS errors). Previous research has identified def-
icits in reversal learning to be present in bipolar mania,
46
consistent with other recent research implicating orbito-
frontalcortexdysfunctioninmania(includingmanicpsy-
chosis), such as the presence of impairment on the Iowa
Gambling Test.
47 Interestingly, reversal learning is intact
in euthymic bipolar disorder without a history of psycho-
sis, suggesting a state-dependent deficit in nonpsychotic
bipolar disorder.
48
Lesionstudiesinrodentsandnonhumanprimateshave
demonstrated a key role for the orbitofrontal cotrex and
ventral striatum in reversal learning.
49–53 Moreover, this
evidence is corroborated from human functional imaging
studies
33,54,55 and from studies of human patients with
orbitofrontal lesions.
56,57 These regions are critical for
motivational and goal-directed processing
10; thus, the
present study suggests that there is dysfunction of orbi-
tofrontal/ventral striatal circuitry in psychosis. This con-
tention is consistent with the findings of our correlational
analysis in patients, which demonstrates that the greater
the reversal impairment, the more severe the negative
symptoms (ie, the greater the impairment in motivational
and goal-directed behavior). We note that the specificity
of this correlation should be viewed with caution because
the magnitude of the significant correlation coefficient be-
tween negative symptoms and reversal errors (q = 0.3) dif-
fered only slightly from the nonsignificant correlation
between positive symptoms and reversal errors (q = 0.2).
Interestingly, we found that the patient group made
few errors at the compound discrimination stage, which
is in contrast with recent results reported by Jazbec
et al.
29 They studied 34 patients with chronic schizo-
phrenia and found pronounced deficits in compound
Table 3. Comparison of Nonaffective Psychosis and Affective
Psychosis Error Scores (Mann-Whitney U Test) in Those Cases
Who Attempted All Stages of the IDED Test: ie, Those Who
Completed At Least the Extradimensional Shift Stage and Who
ThereforeWereAbletoAtLeastAttempttheFinalReversalStage
Nonaffective
Psychosis,
N = 62,
Mean (SD)
Affective
Psychosis,
N = 24,
Mean (SD) zP
Simple
discrimination
0.85 (0.62) 0.88 (0.61)  0.30 .77
Simple reversal 1.32 (0.81) 1.17 (0.48)  0.77 .44
Compound
discrimination 1
1.13 (1.48) 0.88 (1.30)  0.89 .38
Compound
discrimination 2
0.23 (0.58) 0.25 (0.53)  0.47 .64
Compound reversal 1.65 (1.64) 1.58 (1.93)  0.91 .36
Intradimensional
shift
0.82 (1.29) 0.33 (0.92)  2.58 .01
Intradimensional
reversal
1.32 (0.84) 1.29 (0.95)  0.57 .57
Extradimensional
shift
6.26 (4.91) 8.16 (6.54)  0.97 .33
Extradimensional
reversal
5.06 (7.83) 6.46 (10.15)  0.16 .88
Total reversal errors 9.35 (8.47) 20.82 (11.15)  0.54 .59
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riorate with disease progression, though longitudinal re-
search will be required to examine this conjecture.
Ourstudydoeshaveanumberoflimitations.Although
we found deficits in SD learning, the ID/ED test is not
solely or primarily a test of this cognitive domain. Given
that the test starts with SD learning, it is conceivable that
somepsychosispatientsmighthavehadtroubleadjusting
to the task environment in general, leading to an appar-
ent specific deficit in this domain. In addition, there was
only a small range in scores in SD learning, which limits
the power of correlation and regression analyses to detect
associations with clinical variables. For this reason, the
failure to detect association between SD errors and clin-
ical variables should not be overinterpreted. SD learning,
and its association with clinical variables, merits further
investigation in early psychosis in other cognitive para-
digms that focus on SD learning in more detail.
Another limitation of the current study is that the ma-
jority of patients were taking second-generation antipsy-
choticmedications.Suchmedicationsactondopaminergic
and serotonergic systems, and ascending serotonin and
dopamine neurotransmitter systems are known to play
a modulatory role in reinforcement learning pro-
cesses.
51,52,58 There are, however, a number of reasons
why our current results are unlikely to be secondary
to medication effects. First, we note that in a recent
functional magnetic resonance imaging study in healthy
volunteers, a low dose of the dopamine D2/D3 receptor
antagonist, sulpiride, did not modulate brain activations
during reversal learning or impair behavioral reversal
performance.
59 Secondly, we observed a correlation be-
tween the level of negative symptoms and reversal
errors, consistent with the theory that both these meas-
ures are secondary to one underlying pathological pro-
cess. Finally, we have, in recent studies, demonstrated
behavioral and physiological abnormalities during tests
of reinforcement learning and motivational modulations
in unmedicated first-episode psychosis patients.
13,15 Fu-
ture studies should examine reversal learning in unmed-
icated patients with psychosis, its relation to symptoms,
and the extent to which reinforcement and reversal
learning deficits can be modulated by pharmacological
interventions. The relationship between reinforcement
learning and reversal deficits and functional impair-
ments also merits investigation.
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